CUE compared with DTIL: revenue, margins and what each company keeps, and the suppliers and customers both name

CUECue Biopharma, Inc.

Mkt capRevenueRevenue

DTILPrecision Biosciences Inc

Mkt capRevenueRevenue

Compare

CUECue Biopharma, Inc.

DTILPrecision Biosciences Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

CUE: latest quarter is a loss; flow not drawable. DTIL: latest quarter is a loss; flow not drawable.Method ›

Price

rebased to 0%

CUE, solidDTIL, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only CUE 3

—Boehringer Ingelheimunlistedcustomer

—ImmunoScapeunlistedcustomer

—LG Chemunlistedcustomer

Shared 0

No shared counterparties.

Only DTIL 12

TGTXTG Therapeuticscustomer

MXCTMaxcytesupplier

—Cellectisunlistedsupplier

—Duke University

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlistedsupplier

8 more · DTIL chain ›

CUECue Biopharma, Inc.

20.53▼−4.31%· post 20.53

Mkt cap$151.6MRevenue$8MQ2 FY26Revenue$27MFY25

DTILPrecision Biosciences Inc

7.07▼−5.03%· post 7.07

ClosedOct 30 '26

Mkt cap$194.9MRevenue$11MQ1 FY26Revenue$34MFY25

Compare

ClosedOct 30 '26

CUECue Biopharma, Inc.

DTILPrecision Biosciences Inc

20.53▼−4.31%post 20.53

Price

7.07▼−5.03%post 7.07

$151.6M

Mkt cap

$194.9M

Q2 FY26$8M

Revenue

$11MQ1 FY26

FY25$27M

Revenue

$34MFY25

CUE20.53▼−4.31%vsDTIL7.07▼−5.03%ClosedOct 30 '26